Crowdonomics
All companies
EXPERFY logo

EXPERFY

Operating

Experfy, Inc.

Software & AI · AI · Westborough, MA · Founded 2010

AI co-pilot platform for the future of work

Post-money valuation ⓘ
$50.1M
As of Sep 2024 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$1,039,084
Crowd $154K · Private $885K · 2 rounds since 2015
Latest share price
$4.51
Reg CF · Common Stock · Sep 2024 offering price

Financials

FY2022–FY2025 · from SEC filings · hover any figure for its source
$15.4M
−$2.6M
2022
$9.4M
−$1.4M
2023
$9.4M
−$1.4M
2024
$9.3M
$2.2M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 audited*
FY2023 audited*
FY2024 unaudited
FY2025 unaudited
Income statement
Revenue
$15,412,874
$9,436,286
$9,436,286
$9,328,907
Cost of goods sold
$15,709,014
$8,416,856
$8,416,856
$6,153,544
Gross margin
-2%
11%
11%
34%
Net income
-$2,639,309
-$1,409,663
-$1,409,663
$2,216,271
Taxes paid
$34,830
$0
$0
$0
Balance sheet
Cash
$2,334,583
$877,165
$877,165
$471,085
Accounts receivable
$121,765
$14,473
$14,473
$508,783
Total assets
$2,546,201
$951,788
$951,789
$1,006,370
Short-term debt
$272,377
$304,971
$304,970
$34,223
Long-term debt
$2,165,869
$1,944,093
$1,944,093
$0
Total liabilities
$2,438,246
$2,249,064
$2,249,063
$34,223
Other
Headcount
—
21
21
23

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$49.9M
pre-money
Reg CF · Common · Sep 2024

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Raised $153.9K / $5MInvestors 61Post-money $50.1M
Raised $885.2KInvestors 19

Team

5 people
Sarabjot KaurFounder
Co-Founder, Co-CEO, Director

Sarabjot propels Experfy's overall growth strategy and product vision. As a former CEO of a Boston agency, she managed clients like Harvard University and EMC. Sarabjot has held strategic roles at Citigroup, State Street and Fidelity, where she helped build the industry's first web-based wealth management platform. She holds an MS in Applied Sciences from HAU, India and digital marketing training from Rhode Island School of Design.

Dr. Harpreet Singh
Co-Founder, Co-CEO, Director

Dr. Harpreet Singh, a Harvard-trained PhD, is a renowned thought leader who frequently speaks at prestigious events hosted by Forbes, Harvard, and MIT. He hosts the Future of Work Pioneers podcast, featuring notable guests like Mark Cuban and Arianna Huffington. Starting his career on Wall Street, Dr. Singh has been at the forefront of AI innovation since 2014. Harpreet will be providing Form C sign-off as the Company's Principal Accounting Officer.

Harpreet Singh
Co-CEO, Director, Principal Accounting Officer
Mika Holman
Director and Head of Operations

Mika Holman leads the operations and clients relationships at Experfy, ensuring compliance as well as robust pipelining of talent, leading to the growth of Experfy's talent community. In the past she has performed similar functions for Robert Half.

Peter Diamandis
Advisor

Named by Fortune Magazine as one of the World's 50 Greatest Leaders, Dr. Peter Diamandis is the Chairman and CEO of the XPRIZE Foundation, which leads one of the world's leaders in designing and launching large incentive prizes to drive radical breakthroughs for the benefit of humanity. Best known for the $10 million Ansari XPRIZE for private spaceflight, Diamandis is also the co-Founder & Executive Chairman of the Singularity University. Diamandis recently co-Authored Abundance – The Future Is Better Than You Think. Diamandis has founded or co-founded many of the leading entrepreneurial companies in this sector including Zero Gravity Corporation, the Rocket Racing League and Space Adventures. He also counsels somoe of the world’s top enterprises on how to utilize exponential technologies and incentivized innovation to dramatically accelerate their business objectives. Dr. Diamandis attended MIT where he received his degrees in molecular genetics and aerospace engineering, as well as Harvard Medical School where he received his M.D.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 2 of 2 annual reports (FY2024–FY2025)

61 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-AROct 8, 20250001635587-25-000002
    EDGAR
  • Form C-UFeb 11, 20250001665160-25-000227
    EDGAR
  • Form C/AJan 8, 20250001665160-25-000019
    EDGAR
  • Form C/ANov 20, 20240001665160-24-001670
    EDGAR
  • Form C-ARNov 20, 20240001665160-24-001672
    EDGAR
  • Form CSep 9, 20240001665160-24-001297
    EDGAR
  • Form DMar 13, 20150001635587-15-000001
    EDGAR
Source: ManualCIK 0001635587DEShare price $4.51

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.